Serum 25-Hydroxyvitamin D levels and thyroid function tests in patients with Generalized Anxiety Disorder and Depressive Disorder - NI

niversity college of medical sciences and Guru Teg Bahadur Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年5月27日

研究概览

暂无简介。

•1. Patients with age between 18-60 years.
•2. Patient must meet criteria for: Either
•Primary diagnosis of Generalized Anxiety Disorder according to ICD-10 (The ICD-10 Classification of Mental and Behavioural Disorders) [Annexure 1]
•Primary diagnosis of Depressive episode- Mild, moderate or severe, or Recurrent Depressive Disorder according to ICD-10 (The ICD-10 Classification of Mental and Behavioural Disorders) [Annexure 2]
•3. Patients should be able to read Hindi/English

•1. Lifetime ICD-10 diagnosis of schizophrenia, schizoaffective or bipolar disorders.
•2. Patients previously diagnosed with and undergoing treatment for any significant or
•chronic medical illness which alters vitamin D or thyroid hormone levels (renal disease,
•thyroid dysfunction, hepatic disease)
•3. Patients consuming vitamin D supplements in the last 6 months.
•4. Pregnant or lactating women.
•5. Patients with substance dependence of alcohol and illicit substances (except nicotine).
•6. Patients not consenting for participation in the study or for giving blood sample.

发起方

niversity college of medical sciences and Guru Teg Bahadur Hospital